A Study on the Progress of Astragalus-Coptis Chinensis Medicinal Pair in the Treatment of Diabetes Mellitus
DOI:
https://doi.org/10.53469/jcmp.2024.06(06).43Keywords:
Astragalus-Coptis Chinensis and its analogous formulas, Diabetes mellitus, Diabetic complications, Research progressAbstract
According to the relevant studies in recent years, it was found that astragalus - Coptis Chinensis drug pair and its analogous formula have a broad prospect for the treatment of type 2 diabetes mellitus (T2DM). Pharmacological studies have shown that Coptis Chinensis possesses the pharmacological activities of antimicrobial, anti-inflammatory, anti-tumor, lipid regulating, hypoglycemic, anti-arrhythmic, and antioxidant activities[1], and Astragalus possesses the effects of enhancing the function of the immune system, antimyocardial ischemia, bi-directional regulation of blood pressure, anti-tumor, anti-aging, hypoglycemia, and protection of metabolic tissues (liver and kidneys, etc.) [2] [3], the use of Astragalus and Coptis Chinensis pairs has demonstrated significant multiple effects. Specifically, this combination not only effectively reduces blood glucose levels, but also significantly enhances the body's sensitivity to insulin, thus helping to improve the phenomenon of insulin resistance and further enhance the overall health status of patients [1][2][3]. This paper analyzes and researches the research progress of astragalus-Coptis Chinensis medicinal pair and its analogous formulae in the treatment of type 2 diabetes mellitus and the improvement of its complications through the collation and summarization of the literature, in order to lay a certain theoretical research foundation for the clinical diagnosis and treatment of type 2 diabetes mellitus by astragalus-Coptis Chinensis medicinal pair and its related formulae, prevention of diabetes mellitus complications, and rational use of medicines in diabetes mellitus clinical treatment.
References
Fu Lin, Fu Qiang, Li Ji et al. Research progress on the chemical composition and pharmacological effects of Coptis chinensis[J]. Acta Chinese Medicine and Pharmacology, 2021, 49(02):87-92.
Li Bo, Geng Gang. Research progress on the chemical composition and pharmacological effects of Astragalus membranaceus[J]. Research of Integrated Traditional Chinese and Western Medicine, 2022, 14(04):262-264.
Chen Guohui, Huang Wenfeng. Progress in pharmacological effects of compositions of Astragalus membranaceus[J]. Chinese Journal of New Drugs, 2008(17):1482-1485.
Chen Haozhu, Zhong Nanshan, Lu Zaiying; Ge Junbo, Xu Yongjian, WangChen, editors-in-chief; Tang Chengwei, Xiao Haipeng, Wang Jian'an, Zeng Xiaofeng, deputy editors-in-chief. Internal Medicine 9th edition[M]. Beijing: People's Medical Publishing House, 2022.11
2021 Global Diabetes Map (10th Edition) [EB/OL], 2021.
Pang Guoming, Ni Qing, Zhang Fang. Guideline for Diagnosis and Treatment of Type Ⅱ Diabetes based on Syndrome Differentiation Combining with Disease Differentiation[J]. Journal of Traditional Chinese Medicine, 2021, 62(04):361-368.
Zheng Yujiao, Xiao Bing, Liu Wenke, et al. Spleen Dysplasia Theory and Obesity Discussion[J]. Beijing Journal of Traditional Chinese Medicine, 2017, 36 (06): 528-531.
Wei Junping, Yan Weitian, Wei Maoying, et al. Theoretical basis and research literature review on the treatment of newly diagnosed type 2 diabetes mellitus from damp heat[J]. Journal of Medical Research, 2021, 50 (02): 1-4.
Han Liyan. Discussion on the distribution characteristics of TCM constitution and related factors in patients with chronic complications of type 2 diabetes [J]. Shandong University of Traditional Chinese Medicine, 2018.
Fu Jingying, Zhang Yun. Mechanism of Astragali Radix-Coptis Rhizoma pair in treating type 2 diabetes mellitus based on network pharmacology [J]. China Journal of Chinese Materia Medica, 2021, 46(18):4808-4815.
Gao Huiqin, Xu Yan, Wang Mingwei. Journal of Gansu College of Traditional Chinese Medicine, 2013, 30(03):2.
Xiao Kaiwen, LI Xue, Chen Yanqing, et al. Analysis of Zhang Zhongjing's application of compatibility with Astragalus membranaceus. Yunnan Journalof Traditional Chinese Medicine and Materia Medica, 2023, 44 (12): 13-15.
Chinese Pharmacopoeia Commission, ed. Chinese Pharmacopoeia 2020 edition of the four general principles draft[M]. Beijing: China Medical Science and Technology Press, 2019.
Zhang Xia. Overview of chemical composition and pharmacological effects of Astragalus[J]. Journal of Practical Traditional Chinese Medicine, 2013, 29 (07): 608-609.
Zhang Zhengyi, Liu Hailong, Wang Ruiqiong, et al. Chemical Composition and Pharmacological Effects of Astragalus membranaceus and Q-marker Prediction Analysis[J]. Chin J New Drugs, 2023, 32(4):410-419.
LEE D, LEE D H, CHOI S, et al. Identification and isolation of active compounds from Astragalus membranaceus that improve insulin secretion by regulating pancreatic β-cell metabolism[J]. Biomolecules, 2019, 9(10):618.
Song Jia. Effects of Chinese herbal pieces of Radix Astragali on islet secretion and insulin resistance in patients with type 2 diabetes mellitus [J]. Chinese Journal of Modern Drug Application, 2024, 18 (04): 136-138.
LIU M, WU K, MAO X, et al. Astragalus polysaccharide improves insulinsensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle [J]. Journal of ethnopharmacology, 2010, 127(1): 32-7.
ZHANG R, QIN X, ZHANG T, et al. Astragalus Polysaccharide Improves Insulin Sensitivity via AMPK Activation in 3T3-L1 Adipocytes [J]. Molecules (Basel, Switzerland), 2018, 23(10).
Wu Dong, Zhang Qinghong, He Liqun, Yang Shanshan. Astragalus polysaccharide regulates PI3K/AKT pathway to improve kidney injury in diabetic rats[J]. Biotechnology, 1-7.
Yan Lingyun, Yang Shuyu, LI Xuejun. Research Progress of the Control Mechanisms of Astragalus Polysaccharides on Diabetic Nephropathy [J]. Medical Recapitulate, 2012, (11):1727-1729.
Wang Ruihua, Sun Dalin, Wang Jinjing, et al. Astragaloside Ⅳ Alleviates Podocyte Endoplasmic Reticulum Stress in Diabetic Nephropathy by Regulating IRE-1α Signaling Pathway [J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2023, 24 (11): 957-960+1035.
Huang Lixia, Li Xin, Zhang Shu, Fan Yuyan. Mechanism of Astragaloside Ⅳ on diabetic nephropathy induced by Streptozotocin in rats [J]. Beijing Journal of Traditional Chinese Medicine e, 2023, (04):403-407
Hu Yaling. Mechanism of astragaloside IV regulating SIRT1/NF-κB signaling pathway to improve renal tubular epithelial cell injury in diabetic nephropathy[J]. Shanxi Medical University, 2021(02).
Wang Chenxiu, Lin Anhua. The effects of astragalus and its active ingredients on blood glucose and pancreaticβcells in mice with diabetes [J]. China Medicine And Pharmacy, 2023, (12):18-21.
LI Nan, Fan Ying, Jia Xuming, et al. Effect of Astragali Radix Active Ingredients on Serum Insulin and Adiponectin in Diabetes Rats [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2011, 17(5):144-146
Fang WL, Zhao DQ, Wang F, et al. Neurotropin alleviates hippocampal neuron damage through a HIF-1α/MAPK pathway[J]. CNS Neurosci Ther, 2017, 23(5):428－437.
Hou Jun, Cheng Yue, Li Jiazhi, Wei Lai, Wu Qiangpeng, Liu Chaoren, Hou Fang. Protective effect and mechanism of astragalus flavone on dorsal root ganglion in diabetic rats with peripheral neuropathy [J]. Guangxi Medical Journal, 2021, (22):2704-2710.
Wang Qianlin, Xing Zhihua, Zhou You. Research Progress on Chemical Constituents and Pharmacological Effects of Coptis chinensis[J]. Heilongjiang Agricultural Sciences, 2024(03):102-109.
Wang Yu, Li Longyun, Tan Jun, et al. Research for dynamic changes of growth and alkaloids of Coptis chinensis[J]. China Journal of Chinese Materia Medica, 2018, 43(20):4027-4032.
Wu Mengmeng, Zhou Diyi. Application of Coptis chinensis and its compatibility in thirst disease[J]. Chinese Journal of Traditional Chinese Medicine: 1-8[2024-04-28]
Luo Yongjun. Effect of sulfonylurea hypoglycemic drugs combined with berberine and metformin in the treatment of diabetes[J]. Chinese Journal of Clinical Rational Drug Use, 2022, (22):83-86.
Zhao Yan, Lu Fuer. Research Progress on Berberine in the Treatment of Diabetes Mellitus[J]. Research of Integrated Traditional Chinese and Western Medicine, 2010, 2(06): 307-311.
Chen Xin, Huang Jing, Li Panpan, et al. Study on the effect of Coptis chinensis alkaloids on hypoglycemic and oxidative stress in diabetic mice[J]. Asia-Pacific Traditional Medicine, 2012, 8(04):24-25.
Konrad D, Somwar R, Sweeney G, et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation [J]. Diabetes, 001, 50(6):1464–1471.
Li Z, Jiang J D, Kong W J. Berberine up-regulates hepatic low-density lipoprotein receptor through rasindependent but AMP-activated protein kinase- dependent Raf-1 activation [J]. Biol Pharm Bull, 2014, 37(11): 1766-1775.
Yu J, Wu H, Liu ZY, et al. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/ STAT3 pathway activation[J]. Int J Mol Med, 2017, 40(4):1185–1193.
Liu Bo, Wang Li, Ling Shengtao, et al. Berberine Attenuates Renal Fibrosis by Activating Myofibroblast Iron Death [J]. Chinese Journal of Microcirculation, 2023, 33 (04): 21-26.
Ren Yanlin, Wang Dingkun, Dong Hui, et al. Research progress of berberine in treatment of diabetic kidney disease[J]. China Journal of Chinese Materia Medica, 2017, 42 (03): 438-442.
Jin Xia, Yao Xianmei, Wang Chenyuan, Chen Yonglan. Study on the protective effect of Coptis alkaloids on diabetic nephropathy rats [J]. Pharmacology and Clinics of Chinese Materia Medica, 2013, 29(03):82-85.
Yu Yanwei, Zhang Xin, Mao Zhujun. Study on the mechanism of Astragalus-Rhizoma Coptidis in the treatment of type 2 diabetes based on network pharmacology [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2022, 37(04):2235-2240.
Guo Lanyue. Observation on the efficacy of Angelica sinensis Liuhuang decoction in the treatment of diabetic lower limb vascular lesions and its effect on inflammatory factors[D]. Shandong University of Traditional Chinese Medicine, 2024.
Yu Jiali, Wang Dong. Clinical Study on Modified Danggui Liuhuang Decoction Combined with Irbesartan for Type 2 Diabetic Nephropathy with Qi-Yin Deficiency Syndrome[J]. New Chinese Medicine 2023, 55 (02): 40-43.
Li Yanmei. Observation on the efficacy of Angelica sinensis Liuhuang decoction in the treatment of type 2 diabetic hyperhidrosis[J]. Journal of Practical Traditional Chinese Medicine, 2020, 36(10): 1269-1270.
Shao Qiang. Efficacy analysis of Angelica sinensis Liuhuang decoction in the treatment of diabetic pruritus[J]. Diabetes New World Magazine, 2017, 20(08):82-83.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Meimei Wang, Yanjin Su
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
